No effect of tenofovir on infant bone mineral content in African study
1 June 2016. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Paediatric care
Use of modelling to predicting paediatric dosing of long acting antiretrovirals
1 June 2016. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Nevirapine dosing for treatment of neonates
1 June 2016. Related: Conference reports, Paediatric care, PK and drug interactions.
Dolutegravir: 48 week results in children age 6 to 12 years old
22 March 2016. Related: Conference reports, Paediatric care.
Substituting lopinavir/ritonavir with efavirenz in children on stable ART
1 December 2015. Related: Conference reports, Antiretrovirals, Paediatric care.
The effects of systemic efavirenz exposure, sex and age on risk of viral non-suppression
1 December 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
Pharmacokinetics of lopinavir/ritonavir super-boosting in infants and young children co-infected with HIV and TB
1 December 2015. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Protection against flu but not HBV in vaccinated perinatally HIV-infected children
1 October 2015. Related: Conference reports, Paediatric care, Hepatitis coinfection.
Raltegravir for neonates will require a complicated dosing regimen
1 October 2015. Related: Conference reports, Pregnancy, Paediatric care.
Paediatric dosing of DRV/r
1 October 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
FDA approve additional weight band dosing for children using atazanavir powder
1 October 2015. Related: Antiretrovirals, Paediatric care.
Dispersible tablet formulation of dolutegravir is bioequivalent to the granule formulation
1 August 2015. Related: Conference reports, Paediatric care.
The Pediatric Antiretroviral Pipeline
17 July 2015. Related: Pipeline report, Antiretrovirals, Paediatric care.
Momentum in the Pediatric Tuberculosis Treatment Pipeline
17 July 2015. Related: Pipeline report, Paediatric care, TB coinfection.
Other short reports from BHIVA:
1 June 2015. Related: Conference reports, Antiretrovirals, Paediatric care, Basic science and immunology.
Elvitegravir in children and adolescents
1 June 2015. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Point of care HIV PCR test for infant diagnosis: good performance but poorer results in youngest age group
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Diagnostics.
Weekend-off ART is non-inferior to continuous ART in young people taking efavirenz-based regimens: results from BREATHER study
24 March 2015. Related: Conference reports, Treatment strategies, Paediatric care.
Increased cardiovascular risks in HIV positive children in Uganda and Zambia partially reversed by ART
24 March 2015. Related: Conference reports, Paediatric care, Coinfections and complications.
Lopinavir/ritonavir superior to nevirapine in children <3 years old: IMPAACT P1060 five year results
24 March 2015. Related: Conference reports, Paediatric care.
Long-term safety and efficacy of tenofovir in children
24 March 2015. Related: Conference reports, Paediatric care.
Drug resistance in children after PMTCT and early treatment
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Drug resistance.
Pharmacokinetics and safety of moxifloxacin in children
29 January 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
TB in the ARROW trial of children on ART
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
Problems giving current second line TB drugs to children
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
Infants start ART too late but improvement over time in Southern Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Update on paediatric antiretrovirals
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Is d4T a viable option for children in low-income countries?
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents
1 August 2014. Related: Conference reports, Paediatric care.
Rationalising the paediatric antiretroviral formulary in Malawi
1 August 2014. Related: Conference reports, Treatment access, Paediatric care.
Time to first-line failure in the IeDEA cohort
1 August 2014. Related: Conference reports, Paediatric care.
Influence of early ART on antibody detection in children
1 August 2014. Related: Conference reports, Paediatric care.
Wrestling with the implications of the Mississippi case
1 August 2014. Related: Paediatric care, Cure-related research.
The paediatric antiretroviral pipeline
19 July 2014. Related: Pipeline report, Antiretrovirals, Paediatric care.
Playing catch-up: paediatric tuberculosis treatment pipeline
19 July 2014. Related: Pipeline report, Paediatric care, TB coinfection.
Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Early antiretroviral treatment in infants
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Catching up with pathogenesis and cure research from CROI 2014
27 May 2014. Related: Conference reports, Paediatric care, Cure-related research.
Paediatric pipeline: CROI 2014 update on new antiretrovirals for children
24 March 2014. Related: Conference reports, Paediatric care.
Efavirenz maintenance therapy effective in children exposed to nevirapine prophylaxis
24 March 2014. Related: Conference reports, Paediatric care.
FDA approves raltegravir for children older than 4 weeks
24 March 2014. Related: Paediatric care.
Lower immune response to the qHPV vaccine in HIV positive girls
1 February 2014. Related: Conference reports, Women's health, Paediatric care.
HIV exposed vs unexposed babies have lower gestational age and birth weight in Danish study
1 February 2014. Related: Conference reports, Pregnancy, Paediatric care.
Outcomes in infants exposed to lopinavir/ritonavir in utero
1 February 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Preventing and treating TB in children – more baby steps
1 December 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Paediatric guidelines on the prevention and treatment of OIs (November 2013)
1 December 2013. Related: Paediatric care, Guidelines.
WHO 2013 guidelines: what about the missing formulations?
25 July 2013. Related: Conference reports, Treatment access, Paediatric care, Guidelines.
Decreased growth in ART exposed uninfected infants in Botswana
25 July 2013. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Antiretrovirals, doses and formulations for children
25 July 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
The paediatric antiretroviral pipeline
30 June 2013. Related: Pipeline report, Antiretrovirals, Paediatric care.
Population pharmacokinetics of efavirenz to inform dosing in children three months of age and above
29 May 2013. Related: Conference reports, Paediatric care, PK and drug interactions.
Bilirubin as a surrogate marker for atazanavir in children
29 May 2013. Related: Conference reports, Paediatric care, PK and drug interactions.
EU approval for raltegravir in children aged 2 years and older
29 May 2013. Related: Antiretrovirals, Paediatric care.
FDA update label for paediatric efavirenz and capsule sprinkle formulation
29 May 2013. Related: Antiretrovirals, Paediatric care.
Five-year results from the AntiRetroviral Research for Watoto (ARROW) Trial
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Comparison of ritonavir-boosted lopinavir or NNRTI ART and PK with antimalarials in Ugandan children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics and acceptability of lopinavir/ritonavir sprinkles in children aged 1 to 4 years
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Pharmacokinetics of currently available antiretroviral options for young children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, PK and drug interactions.
Tenofovir use in children
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
ddI resistance in South African children failing an abacavir or d4T based first-line regimen
1 April 2013. Related: Conference reports, Antiretrovirals, Paediatric care, Drug resistance.
Report of a functional cure in an HIV infected infant
1 April 2013. Related: Conference reports, Paediatric care, Cure-related research.
Once-daily option for paediatric use of darunavir/ritonavir
1 April 2013. Related: Paediatric care.
Paediatric TB: glimpses of PK data and a potential new approach to drug development
1 February 2013. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
New UNITAID grants focus on paediatric HIV, TB and malaria
1 February 2013. Related: Treatment access, Paediatric care, TB coinfection.
The American Academy of Pediatrics recommends that HIV positive mothers not breastfeed their infants, regardless of maternal viral load and ART
1 February 2013. Related: Pregnancy, Paediatric care.